Efficacy and safety of neoadjuvant toripalimab plus chemotherapy in localized deficient mismatch repair/microsatellite instability-high gastric or esophagogastric junction adenocarcinoma (NICE): a multicentre, single-arm, exploratory phase 2 study

ABSTRACT:

SUBMITTER: Zhao L 

PROVIDER: S-EPMC12361998 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature